Medical Science Liaison

Responsibilities

• Build and maintain credible therapy area and product knowledge to support launches in Rare Bone & Endocrinology and Rare Tumours.
• Establish and grow scientific partnerships with regional thought leaders, KEEs, and specialist centres.
• Drive scientific exchange with HCPs and gather actionable insights to inform medical strategy and tactical planning.
• Facilitate clinical pathway mapping and service optimisation initiatives in collaboration with cross-functional teams.
• Identify and progress potential research collaborations with centres of excellence.
• Ensure all activities comply with the ABPI Code of Practice, company policies, and pharmacovigilance requirements.
• Operate as a field medical expert with considerable national and occasional international travel.

Requirements

• Bachelor’s degree in a scientific discipline (e.g., Medicine, Pharmacy, or disease-related science).
• Valid UK driving license.
• Experience in relationship and stakeholder management.
• Understanding of the UK rare disease healthcare landscape.
• Knowledge of the ABPI Code of Practice and its practical application.
• Excellent oral and written communication skills with the ability to interpret complex clinical information.
• Ability to work effectively both independently and within a cross-functional team environment.

Preferred Qualifications

• Higher degree in a science or business subject.
• Existing knowledge of relevant rare disease therapy areas.
• Experience in medical affairs, clinical practice, or the pharmaceutical/biotech industry.
• Project management accreditation or experience within medical affairs.
• Demonstrated leadership, initiative, and problem-solving skills.

About the Company

AstraZeneca is a global, science-led biopharmaceutical company that focuses on discovering, developing, and commercializing prescription medicines. Through our work in rare diseases, we aim to turn science into meaningful change for patients living with conditions such as HPP, HypoPT, and NF1.